Elanco (ELAN) executive logs tax-withholding share disposition in Form 4

Rhea-AI Filing Summary

Elanco Animal Health Inc executive David S. Kinard reported a Form 4 transaction involving company common stock. On March 3, 2026, Kinard had a tax-related disposition of 3,433 shares of common stock at a reported price of $24.88 per share. This transaction is coded as a tax-withholding disposition, meaning shares were surrendered to cover tax obligations rather than being sold on the open market. After this transaction, Kinard directly held 214,264 shares of Elanco Animal Health Inc common stock.

Insider Trade Summary

Net Seller: 3,433 shares

Net Sell 1 txn

Insider Kinard David S

Role SEE REMARKS

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	3,433	$24.88	$85K

Holdings After Transaction: Common Stock — 214,264 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/05/2026 - 04:11 PM Learn about SEC filing dates

FAQ

What insider transaction did David S. Kinard report at ELAN?

David S. Kinard reported a tax-related disposition of 3,433 Elanco Animal Health common shares. The shares were used to satisfy tax obligations, not an open-market sale, and the transaction was reported on a Form 4 as a tax-withholding disposition.

How many Elanco (ELAN) shares did David S. Kinard dispose of for taxes?

David S. Kinard disposed of 3,433 Elanco Animal Health common shares to cover tax liabilities. This tax-withholding disposition reduced his holdings while avoiding a separate cash payment of taxes associated with equity compensation reported in the Form 4 filing.

What was the reported price per share in David S. Kinard’s ELAN Form 4?

The Form 4 lists a price of $24.88 per Elanco Animal Health common share for the 3,433-share tax-withholding disposition. This figure is a reporting value tied to the transaction and not necessarily an open-market trade execution price.

How many Elanco (ELAN) shares does David S. Kinard hold after this transaction?

After the reported tax-withholding disposition, David S. Kinard directly holds 214,264 Elanco Animal Health common shares. This post-transaction balance reflects his continuing equity stake as disclosed in the Form 4 ownership table for this insider filing.

Was David S. Kinard’s ELAN transaction a market sale or tax withholding?

The transaction was a tax-withholding disposition, not an open-market sale. Shares were delivered to satisfy tax obligations tied to equity compensation, as indicated by transaction code F and the tax-withholding description in the Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kinard David S

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEE REMARKS

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		F		3,433	D	$24.88	214,264	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Executive Vice President, Human Resources, Corporate Affairs and Administration

	/s/ Amy C. Seidel, as Attorney-in-Fact for David S. Kinard	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.